statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

EVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTS

EVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTS EVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTS PR...

Evotec And Claris Ventures Streamline Access to Accelerate Programmes from Claris's Portfolio Companies into The Clinic

CLARIS'S PORTFOLIO COMPANIES RECEIVE EASY ACCESS TO EVOTEC'S FULL RANGE OF PRE-CLINICAL AND CLINICAL DEVELOPMENT AND MANUFACTURING CAPABILITIESAGREEMENT BUILDS ON SUCCESSFUL COLLABORATION BETWEEN...

Evotec SE (EVO, $7.83) Moving Average Convergence Divergence (MACD) Histogram turned positive on February 7, 2024

This is a Bullish indicator signaling EVO's price could rise from here. Traders may explore going long the stock or buying call options...

Just - Evotec Biologics Expands Development and Manufacturing Agreement with ABL for Broadly Neutralising Antibodies Against HIV

JUST - EVOTEC BIOLOGICS TO PROVIDE DEVELOPMENT AND PHASE I CLINICAL MANUFACTURING OF BROADLY NEUTRALISING ANTIBODY AGAINST HIVAGREEMENT BUILDS ON PREVIOUS NIAID-FUNDED COLLABORATION TO DEVELOP A...

Evotec SE (EVO, $7.65) RSI Indicator left the oversold zone on February 06, 2024

This is a signal that EVO's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...

Evotec SE (EVO, $8.19) RSI Indicator left the oversold zone on January 24, 2024

Evotec SE (EVO, $8.31) RSI Indicator left the oversold zone on January 22, 2024

Evotec SE (EVO) Business Update Conference Call (Transcript)

Evotec SE (EVO) Business Update Conference Call (Transcript...

Evotec SE: Invitation to Conference Call

HAMBURG, GERMANY / ACCESSWIRE / January 22, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) is going to hold a conference call to provide a statement as...

Short Interest in Evotec SE (NASDAQ:EVO) Rises By 162.1%

Evotec SE (NASDAQ:EVO  Get Free Report) saw a significant increase in short interest in December. As of December 31st, there was short interest totalling 22,800 shares, an increase of 162.1...

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties. The EVT Innovate develops drug discovery projects, assets and platforms, both internally or through academic collaborations. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, and Charles Weissmann on December 8, 1993 and is headquartered in Hamburg, Germany.

Volume	13,079.00
52-Wk High	$13.22
52-Wk Low	$3.94

EVO Eaton Vance Ohio Municipal Income Trust

About

Feed

News

Sentiment

Fundamentals